India’s pharmaceutical exports registered slowest growth in at least 15 years at 1.2 per cent to $14.84 billion last fiscal amid growing tension with the US over intellectual property rights related issues.
As the IPR issues raised by the US — India’s biggest market — are unlikely to be resolved anytime soon, industry observers say that pharma exports will miss the target of $25 billion set for 2014-15 in a government strategy paper.
According to the Commerce Ministry data, in 2012-13, the country’s pharma exports aggregated $14.66 billion. Business Line
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…